Assessing the impact of a safe and equitable biosimilar policy in the United States: hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 2, 2007.

by United States House of Representatives, Committee on Energy and Commerc (house), and United S Congress

0 ratings • 0 reviews • 0 shelved
Book cover for Assessing the impact of a safe and equitable biosimilar policy in the United States
Shelve It

Bookhype may earn a small commission from qualifying purchases. Full disclosure.

  • ISBN10 1700993429
  • ISBN13 9781700993427
  • Publish Date 20 October 2019
  • Publish Status Temporarily Withdrawn
  • Imprint Independently Published
  • Format Paperback (US Trade)
  • Pages 192
  • Language English